The present invention relates to topical ophthalmological pharmaceutical compositions containing regorafenib, a hydrate, solvate or pharmaceutically acceptable salt thereof or a polymorph thereof but without hydrophobic silica and its process of preparation and its use for treating ophthalmological disorders.本發明係關於包含雷格拉非尼(Regorafenib)的局部眼科醫藥組成物,水合物,溶劑合物或製藥上可接受的鹽或其多晶型物,但無疏水性二氧化矽,及其製備方法及其於治療眼科疾病之用途。